Discovery of dual GyrB/ParE inhibitors active against Gram-negative bacteria

Eur J Med Chem. 2018 Sep 5:157:610-621. doi: 10.1016/j.ejmech.2018.08.025. Epub 2018 Aug 11.

Abstract

Even though many GyrB and ParE inhibitors have been reported in the literature, few possess activity against Gram-negative bacteria. This is primarily due to limited permeability across Gram-negative bacterial membrane as well as bacterial efflux mechanisms. Permeability of compounds across Gram-negative bacterial membranes depends on many factors including physicochemical properties of the inhibitors. Herein, we show the optimization of pyridylureas leading to compounds with potent activity against Gram-negative bacterial species such as P.aeruginosa, E.coli and A.baumannii.

Keywords: Dual target inhibition; Gram-negative bacteria; Gyrase; Gyrase B; ParE; TopoIV.

MeSH terms

  • Anti-Bacterial Agents / chemical synthesis
  • Anti-Bacterial Agents / chemistry
  • Anti-Bacterial Agents / pharmacology*
  • DNA Gyrase / metabolism*
  • DNA Topoisomerase IV / antagonists & inhibitors*
  • DNA Topoisomerase IV / metabolism
  • Dose-Response Relationship, Drug
  • Drug Discovery*
  • Escherichia coli / drug effects*
  • Escherichia coli / enzymology
  • Microbial Sensitivity Tests
  • Molecular Structure
  • Streptococcus pneumoniae / drug effects
  • Streptococcus pneumoniae / enzymology
  • Structure-Activity Relationship
  • Topoisomerase Inhibitors / chemical synthesis
  • Topoisomerase Inhibitors / chemistry
  • Topoisomerase Inhibitors / pharmacology*

Substances

  • Anti-Bacterial Agents
  • Topoisomerase Inhibitors
  • DNA Topoisomerase IV
  • DNA Gyrase